TARASA QUINTANILLA: Open Payments
NPI 1275259814 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 26 payments from 13 companies in 2025. Trend: 2023 $249 · 2024 $401 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $247 |
| Novo Nordisk Inc | 4 | $97 |
| PFIZER INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Amgen Inc. | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $33 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
Products named: AIRSUPRA, PREVNAR 20, FARXIGA, Cologuard Collection Kit, SHINGRIX, ZORYVE, Veozah, Wegovy.
Industry payments across CA — which companies pay providers there.
